SCHEMBL9658698

SCHEMBL9658698

CCCCCCCCCCCCCCCCCCOCN(C)CCC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.43
THRB P10828 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
MAPT P10636 1/20 0.43
SPHK1 Q9NYA1 1/20 0.42
DNM1 Q05193 4/20 0.41
CES2 O00748 2/20 0.41
ALDH1A1 P00352 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
USP2 O75604 1/20 0.38
LSS P48449 1/20 0.37
CES1 P23141 1/20 0.37
PRKD3 O94806 1/20 0.37
PRKCG P05129 1/20 0.37
PRKCB P05771 1/20 0.37
PRKCA P17252 1/20 0.37
PRKCH P24723 1/20 0.37
PRKCI P41743 1/20 0.37
PRKCE Q02156 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19835254 1.00 HTT (0.43) HTTTHRBMEN1KMT2AMAPT
SCHEMBL19835199 1.00 HTT (0.43) HTTTHRBMEN1KMT2AMAPT
SCHEMBL19834961 0.85 LPAR3 (0.44)
SCHEMBL2900302 0.84 MEN1 (0.52) HTTTHRBMEN1KMT2AMAPT
SCHEMBL7286646 0.83 MEN1 (0.41) HTTTHRBMEN1KMT2AMAPT
SCHEMBL7286622 0.83 CES2 (0.31) CES2
SCHEMBL7285766 0.83 S1PR2 (0.40) HTTTHRBMEN1KMT2AMAPT
SCHEMBL7351088 0.83 MEN1 (0.50) HTTTHRBMEN1KMT2AMAPT
SCHEMBL23696250 0.83 MEN1 (0.48) HTTTHRBMEN1KMT2AMAPT
SCHEMBL20017922 0.83 HTT (0.48) HTTTHRBMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200078272-A1 METHOD FOR PRODUCING CERAMIDE MICROPARTICLE DISPERSION KAO CORPORATION (JP) 2020-03-12 US disclosed
EP-3536399-A1 METHOD FOR PRODUCING CERAMIDE MICROPARTICLE DISPERSION Kao Corporation (JP) 2019-09-11 EP disclosed
EP-3275448-A1 NUCLEIC ACID-CONTAINING LIPID NANOPARTICLES Kyowa Hakko Kirin Co., Ltd. (JP) 2018-01-31 EP disclosed
EP-0466211-A1 Antistatic multiply films W.R. Grace & Co.-Conn. (US) 1992-01-15 EP disclosed
US-5025922-A Aromatic sulfonamide W. R. GRACE & CO.-CONN. (US) 1991-06-25 US disclosed
US-5024792-A Mixing hydrophilic copolymer with stable hydrophobic aromatic sulfonamides W. R. GRACE & CO.-CONN. (US) 1991-06-18 US disclosed
US-5001015-A Antistatic polyolefin compositions and antistatic polyolefin films made therefrom, including oriented films W. R. GRACE & CO.-CONN. (US) 1991-03-19 US disclosed
US-4899521-A AROMATIC SULFONAMIDE W. R. GRACE & CO. - CONN. (US) 1990-02-13 US disclosed
US-4898771-A Agent for imparting antistatic characteristics to a thermoplastic polymer and a thermoplastic polymer composition containing the agent W. R. GRACE & CO.-CONN. (US) 1990-02-06 US disclosed
US-4882894-A MULTILAYER POLYAMIDES, POLYETHYLENE WITH BENZENESULFONAMIDES W. R. GRACE & CO.-CONN. (US) 1989-11-28 US disclosed
US-4800115-A POLYOXYALKYLENE GLYCOLS ETHERIFIED, POLYETHYLENE, MONOGLYCERIDES W. R. GRACE & CO. (US) 1989-01-24 US disclosed
EP-0264269-A1 Use of thermoplastic polymer composition film containing an antistatic agent W.R. Grace & Co.-Conn. (US) 1988-04-20 EP disclosed
EP-0264270-A2 Thermoplastic polymer composition having antistatic characteristics W.R. Grace & Co.-Conn. (US) 1988-04-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200078272-A1 METHOD FOR PRODUCING CERAMIDE MICROPARTICLE DISPERSION SGMS1, CERS2, SGMS2 HTT 4433/4885THRB 4859/4885MEN1 903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.